Search

Your search keyword '"Manfredi, Mariangela"' showing total 354 results

Search Constraints

Start Over You searched for: Author "Manfredi, Mariangela" Remove constraint Author: "Manfredi, Mariangela" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
354 results on '"Manfredi, Mariangela"'

Search Results

5. Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy

7. JAK inhibitors and autoimmune rheumatic diseases

8. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations

11. Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study

13. Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience

16. Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience

17. Do Ultrasound Lung Abnormalities Correlate to Biomarkers and Male Gender in Rheumatoid Arthritis Patients? A Monocentric Cross-Sectional Study.

19. Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain

20. Real-Life Comparison of Four JAK Inhibitors in Rheumatoid Arthritis (ELECTRA- i Study).

22. Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases

25. Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174

26. The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective

28. Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine

29. Comparison of current methods for anti‐dsDNA antibody detection and reshaping diagnostic strategies

30. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome

31. Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID‐19 severity: An Italian study

32. Current technologies for anti-ENA antibody detection: State-of-the-art of diagnostic immunoassays

33. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease

36. The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers

37. Vaccination for SARS-CoV-2 in Patients With Psoriatic Arthritis: Can Therapy Affect the Immunological Response?

38. Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test

39. Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data

40. The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays

47. Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammation

48. Integrating quality assurance in autoimmunity: the changing face of the automated ANA IIF test

49. Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales?

Catalog

Books, media, physical & digital resources